AssistRx Enhances Therapy Initiation Solutions with Non-Commercial Specialty Pharmacy
05 nov. 2019 10h00 HE
|
AssistRx
ORLANDO, Fla., Nov. 05, 2019 (GLOBE NEWSWIRE) -- AssistRx, the intelligent specialty therapy initiation and patient support company, today announced the launch of its non-commercial specialty...
AssistRx Appoints Jan Nielsen as Division President of Patient Solutions Business
10 sept. 2019 09h30 HE
|
AssistRx
ORLANDO, Fla., Sept. 10, 2019 (GLOBE NEWSWIRE) -- AssistRx, the intelligent specialty therapy initiation and patient support company, announced today the appointment of Jan Nielsen as division...
BioDelivery Sciences Announces Upcoming Investor Conference Presentations
29 mai 2019 16h10 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., May 29, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences Strengthens Financial Position with Debt Refinancing
28 mai 2019 16h10 HE
|
BioDelivery Sciences International, Inc.
New Agreement is Cash Flow Accretive, Lowers Cost of Capital and Extends Debt Maturity Reduces Annual Interest Costs by Approximately $1.5 million Increases Flexibility to Continue Growth Trajectory...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ended December 31, 2018 and Provides Conference Call Information
11 févr. 2019 17h34 HE
|
Elite Pharmaceuticals, Inc.
Conference Call Scheduled for Tuesday, February 12th at 11:30 AM EST NORTHVALE, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2019 Financial Results on February 12, 2019
07 févr. 2019 06h00 HE
|
Elite Pharmaceuticals, Inc.
Northvale, NJ, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information
09 nov. 2018 16h45 HE
|
Elite Pharmaceuticals, Inc.
Conference Call Scheduled for Monday, November 12th at 11:30 AM EST NORTHVALE, N.J., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
14 août 2018 07h48 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2019 Ended June 30, 2018 and Provides Conference Call Information
09 août 2018 16h43 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2019 Financial Results on August 10, 2018
07 août 2018 16h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...